1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Radotinib: new trials by email Literature Review of Radotinib trials Research Report on Radotinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI Radotinib - Leukemia, Leukemia, Myeloid | Phase 1 / Phase 2 | Completed | Il-Yang Pharm. Co., Ltd. | 85 | 2008-07-01 | 2018-08-29 |
Hematologic Diseases (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Philadelphia Chromosome (1)
India (1) · South Korea (1) · Thailand (1)
IL-yang Pharm (1)